InvestlyInvestly

Corporate announcements, screener tools, and fundamental analysis for NSE-listed companies.

Markets

Top GainersTop LosersMost ActiveIndices

Reports

DealsRumoursInsider TradingInsider XBRL

Platform

AnnouncementsProfileLogin
Investly|

© 2026 Investly.

Privacy Policy
InvestlyInvestly
Announcements
Login
InvestlyInvestly
G

Guest

Login to continue

Login

Markets

Top GainersTop LosersMost ActiveActive Contracts52 Week High52 Week LowPrice Band HittersETFs
Announcements

Reports

Rumour VerificationBulk / Block / Short DealsInsider TradingInsider XBRL
|
Home
/Stocks
/Morepen Laboratories Limited

Morepen Laboratories Limited

NSE: MOREPENLABBSE: 500288
₹23.57
-0.13(-0.55%)
As of 09-Feb-1996
₹23.57-0.13 (-0.55%)As of 09-Feb-1996

MOREPENLAB

NSE · EQ

₹23.57

-0.13 (-0.55%)

Delayed12:00 am

Market Stats

Open

--

Prev. Close

--

Low

₹113.00

High

₹123.55

Circuit (Lower–Upper)

----

52-Week (Low–High)

----
Volume8,656
Avg. Traded Price--

Market Depth

QtyBid PriceAsk PriceQty
--
----
--
--
----
--
--
----
--
--
----
--
--
----
--
Total buy qty.Total sell qty.
50.0% (0)(0) 50.0%

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Market Cap

₹ 6,769.42 Cr

Current Price

₹ 23.57

High / Low

--

Stock P/E

45.88

Book Value

₹ 22.75

Dividend Yield

0.16 %

ROCE

10.19 %

ROE

9.75 %

Face Value

₹ 2

Morepen Laboratories Limited — Price Chart

-0.34 (-1.42%)

Profit & Loss

Showing: Net Sales

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Net Sales
1,188.06 Cr1,546.83 Cr1,417.53 Cr1,690.43 Cr1,811.58 Cr
Total Expenditure
1,069.54 Cr1,410.15 Cr1,338 Cr1,531.81 Cr1,637.51 Cr
Operating Profit
118.51 Cr136.67 Cr79.53 Cr158.62 Cr174.07 Cr
Other Income
12.07 Cr20.1 Cr6.13 Cr13.97 Cr18.36 Cr
Interest
1.79 Cr2.43 Cr1.98 Cr3.71 Cr8.34 Cr
Depreciation
30.28 Cr27.64 Cr27.93 Cr33.47 Cr28.98 Cr
Exceptional Items
0 Cr0 Cr0 Cr0 Cr0 Cr
Profit Before Tax
98.51 Cr126.7 Cr55.76 Cr135.42 Cr155.11 Cr
Tax
1.42 Cr25.02 Cr17.08 Cr38.8 Cr37.09 Cr
Profit After Tax
97.09 Cr101.68 Cr38.68 Cr96.62 Cr118.02 Cr
Adjustments
0 Cr0 Cr0 Cr-0.46 Cr0.01 Cr
Consolidated Net Profit
97.09 Cr101.68 Cr38.68 Cr96.16 Cr118.02 Cr
Adjusted EPS (Rs.)
2.16 Cr2.13 Cr0.76 Cr1.88 Cr2.15 Cr

Ratios

Showing: Debtor Days

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
25 Cr40 Cr31 Cr31 Cr30 Cr42 Cr23 Cr22 Cr30 Cr27 Cr49 Cr34 Cr
Inventory Days
70 Cr82 Cr63 Cr60 Cr62 Cr100 Cr84 Cr107 Cr119 Cr192 Cr221 Cr220 Cr
Days Payable
25 Cr15 Cr24 Cr37 Cr34 Cr29 Cr12 Cr4 Cr6 Cr9 Cr9 Cr35 Cr
Cash Conversion Cycle
69 Cr107 Cr70 Cr54 Cr59 Cr112 Cr95 Cr125 Cr142 Cr210 Cr261 Cr220 Cr
Working Capital Days
-9 Cr-3 Cr-5 Cr1 Cr5 Cr17 Cr16 Cr23 Cr12 Cr11 Cr19 Cr-16 Cr
ROCE %
-27.00%17.00%24.00%32.00%35.00%21.00%11.00%7.00%5.00%5.00%5.00%

Morepen Laboratories Limited Shareholding

MetricDEC 2022MAR 2023JUN 2023SEP 2023DEC 2023MAR 2024JUN 2024SEP 2024DEC 2024MAR 2025JUN 2025SEP 2025
Promoters
41.6341.6341.6441.6441.8641.8641.8641.9442.2242.2242.2242.23
FIIs
2.132.061.931.932.001.871.871.400.940.940.981.01
Public
56.2456.3256.4456.4156.1356.2756.2656.6656.8556.8556.8056.76

Peer Comparison

No peer comparison data available.

Deals & Short Selling

Last 365 Days

No bulk deals found for this stock.

Corporate Filings & Announcements

About Morepen Laboratories Limited

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Sector

Healthcare

Industry

Pharmaceuticals & Biotechnology

Basic Industry

Pharmaceuticals

MOREPENLAB

NSE · EQ

₹23.57

-0.13 (-0.55%)

Delayed12:00 am

Market Stats

Open

--

Prev. Close

--

Low

₹113.00

High

₹123.55

Circuit (Lower–Upper)

----

52-Week (Low–High)

----
Volume8,656
Avg. Traded Price--

Market Depth

QtyBid PriceAsk PriceQty
--
----
--
--
----
--
--
----
--
--
----
--
--
----
--
Total buy qty.Total sell qty.
50.0% (0)(0) 50.0%